Atlas Trials

A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases

Clinical trial NCT06774664 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06774664
Sponsor
Sinocelltech Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
IgA Nephropathy
Start date
2025-01-01
Primary completion
2027-09-01
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.